The Neuropathology Core's main goal is to obtain, characterize, store and distribute for research, tissue specimens from longitudinally followed dementia patients and control research subjects from the Oregon Alzheimer Disease Center (OADC) Clinical Core, as well as selected patients from throughout the State of Oregon. All available specimens from subjects studied by the Center will be obtained and analyzed as rapidly as possible post-mortem. The Neuropathology Core will apply state-of-the-art, standardized protocols and staining methods to characterize the autopsy tissue quantitatively and semi-quantitatively and render a diagnosis. Approaches used to analyze tissue will include molecular, biochemical, immunological, histochemical and morphometric techniques. These methods will be applied to an increasing number of autopsy specimens from clinically well characterized individuals from the Clinical Core. Tissue will be provided to local and national investigators utilizing these tissues for hypothesis driven research and the development of novel probes and techniques. Data on brain and general autopsy will be entered into coded data forms, checked for accuracy and completeness and subsequently entered by the Data Management Core.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG008017-10
Application #
6295492
Study Section
Project Start
1999-04-01
Project End
2000-03-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
10
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Oregon Health and Science University
Department
Type
DUNS #
009584210
City
Portland
State
OR
Country
United States
Zip Code
97239
Simon, Matthew J; Wang, Marie X; Murchison, Charles F et al. (2018) Transcriptional network analysis of human astrocytic endfoot genes reveals region-specific associations with dementia status and tau pathology. Sci Rep 8:12389
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Croff, Raina L; Witter Iv, Phelps; Walker, Miya L et al. (2018) Things Are Changing so Fast: Integrative Technology for Preserving Cognitive Health and Community History. Gerontologist :
Boespflug, Erin L; Simon, Matthew J; Leonard, Emmalyn et al. (2018) Targeted Assessment of Enlargement of the Perivascular Space in Alzheimer's Disease and Vascular Dementia Subtypes Implicates Astroglial Involvement Specific to Alzheimer's Disease. J Alzheimers Dis 66:1587-1597
Proulx, Jeffrey; Croff, Raina; Oken, Barry et al. (2018) Considerations for Research and Development of Culturally Relevant Mindfulness Interventions in American Minority Communities. Mindfulness (N Y) 9:361-370
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194
Promjunyakul, Nutta-On; Dodge, Hiroko H; Lahna, David et al. (2018) Baseline NAWM structural integrity and CBF predict periventricular WMH expansion over time. Neurology 90:e2119-e2126
Gallagher, Damien; Kiss, Alex; Lanctot, Krista et al. (2018) Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. Am J Geriatr Psychiatry 26:819-827
Silbert, Lisa C; Lahna, David; Promjunyakul, Nutta-On et al. (2018) Risk Factors Associated with Cortical Thickness and White Matter Hyperintensities in Dementia Free Okinawan Elderly. J Alzheimers Dis 63:365-372
Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064

Showing the most recent 10 out of 482 publications